272 related articles for article (PubMed ID: 12209679)
1. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma.
Acs G; Zhang PJ; Rebbeck TR; Acs P; Verma A
Cancer; 2002 Sep; 95(5):969-81. PubMed ID: 12209679
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
Acs G; Xu X; Chu C; Acs P; Verma A
Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
[TBL] [Abstract][Full Text] [Related]
3. Expression of erythropoietin and its receptor increases in colonic neoplastic progression: the role of hypoxia in tumorigenesis.
Gombos Z; Danihel L; Repiska V; Acs G; Furth E
Indian J Pathol Microbiol; 2011; 54(2):273-8. PubMed ID: 21623073
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
[TBL] [Abstract][Full Text] [Related]
5. Expression of erythropoietin and erythropoietin receptor in cervical cancer and relationship to survival, hypoxia, and apoptosis.
Leo C; Horn LC; Rauscher C; Hentschel B; Liebmann A; Hildebrandt G; Höckel M
Clin Cancer Res; 2006 Dec; 12(23):6894-900. PubMed ID: 17145806
[TBL] [Abstract][Full Text] [Related]
6. Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells.
Acs G; Chen M; Xu X; Acs P; Verma A; Koch CJ
Cancer Lett; 2004 Oct; 214(2):243-51. PubMed ID: 15363551
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin and erythropoietin receptor expression in human cancer.
Acs G; Acs P; Beckwith SM; Pitts RL; Clements E; Wong K; Verma A
Cancer Res; 2001 May; 61(9):3561-5. PubMed ID: 11325818
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin and its receptor in breast cancer: correlation with steroid receptors and outcome.
Pelekanou V; Kampa M; Kafousi M; Dambaki K; Darivianaki K; Vrekoussis T; Sanidas E; Tsiftsis DD; Stathopoulos EN; Castanas E
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2016-23. PubMed ID: 17932349
[TBL] [Abstract][Full Text] [Related]
9. Expression of erythropoietin and its receptor in neuroblastomas.
Sartelet H; Fabre M; Castaing M; Bosq J; Racu I; Lagonotte E; Scott V; Lecluse Y; Barette S; Michiels S; Vassal G
Cancer; 2007 Sep; 110(5):1096-106. PubMed ID: 17647284
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of erythropoietin and erythropoietin receptor in tongue squamous cell carcinoma.
Li HG; Li JS; Chen WL; Wang L; Wu DH; Lin ZY
Br J Oral Maxillofac Surg; 2009 Sep; 47(6):470-5. PubMed ID: 19559511
[TBL] [Abstract][Full Text] [Related]
12. The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors.
Vukelic J; Dobrila-Dintinjana R; Jonjic N; Dekanic A; Ilijic V
Med Hypotheses; 2013 Dec; 81(6):1155-8. PubMed ID: 24134826
[TBL] [Abstract][Full Text] [Related]
13. Functional erythropoietin autocrine loop in melanoma.
Kumar SM; Acs G; Fang D; Herlyn M; Elder DE; Xu X
Am J Pathol; 2005 Mar; 166(3):823-30. PubMed ID: 15743794
[TBL] [Abstract][Full Text] [Related]
14. STAT3 and hypoxia induced proteins--HIF-1alpha, EPO and EPOR in relation with Bax and Bcl-xL in nodal metastases of ductal breast cancers.
Wincewicz A; Koda M; Sulkowska M; Kanczuga-Koda L; Wincewicz D; Sulkowski S
Folia Histochem Cytobiol; 2009 Jan; 47(3):425-30. PubMed ID: 20164027
[TBL] [Abstract][Full Text] [Related]
15. Differential up-regulation of erythropoietin and its receptor in benign and malignant prostatic tissue.
Xu C; Zhou T; He M; Sun Y
Urol Oncol; 2010; 28(3):314-9. PubMed ID: 19070519
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin-responsive sites in normal and malignant human lung tissues.
Yasuda Y; Hara S; Hirohata T; Koike E; Yamasaki H; Okumoto K; Hoshiai H
Anat Sci Int; 2010 Dec; 85(4):204-13. PubMed ID: 20397063
[TBL] [Abstract][Full Text] [Related]
17. Survival and invasiveness of astrocytomas promoted by erythropoietin.
Mohyeldin A; Dalgard CL; Lu H; Mcfate T; Tait AS; Patel VC; Wong K; Rushing E; Roy S; Acs G; Verma A
J Neurosurg; 2007 Feb; 106(2):338-50. PubMed ID: 17410721
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of erythropoietin receptor by nitric oxide mediates hypoxia preconditioning.
Chen ZY; Wang L; Asavaritkrai P; Noguchi CT
J Neurosci Res; 2010 Nov; 88(14):3180-8. PubMed ID: 20806411
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer.
Larsson AM; Jirström K; Fredlund E; Nilsson S; Rydén L; Landberg G; Påhlman S
Clin Cancer Res; 2009 Sep; 15(17):5552-9. PubMed ID: 19706814
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis.
Yang Z; Sun B; Zhao X; Shao B; An J; Gu Q; Wang Y; Dong X; Zhang Y; Qiu Z
Int J Clin Exp Pathol; 2015; 8(4):4033-43. PubMed ID: 26097591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
